Visual Universitätsmedizin Mainz

Veröffentlichungen aus 2020

  • Becker C, Graf N, Grabow D, Creutzig U, Reinhardt D, Weyer-Elberich V, et al. Early deaths from childhood cancer in Germany 1980-2016. Cancer epidemiology. 2020;65:101669.

  • Clemens E, Broer L, Langer T, Uitterlinden AG, de Vries ACH, van Grotel M, et al. Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. Pharmacogenomics J. 2020;20(2):294-305.

  • Erdmann F, Frederiksen LE, Bonaventure A, Mader L, Hasle H, Robison LL, et al. Childhood cancer: Survival, treatment modalities, late effects and improvements over time. Cancer epidemiology. 2020:101733.

  • Erdmann F, Hvidtfeldt UA, Feychting M, Sorensen M, Raaschou-Nielsen O. Is the risk of childhood leukemia associated with socioeconomic measures in Denmark?: A nationwide register-based case-control study. Int J Cancer. 2020;(10):915-929.

  • Erdmann F, Hvidtfeldt UA, Sorensen M, Raaschou-Nielsen O. Socioeconomic differences in the risk of childhood central nervous system tumors in Denmark: a nationwide register-based case-control study. Cancer causes & control : CCC. 2020;31(10):915-29.

  • Feijen EAM, van Dalen EC, van der Pal HJH, Reulen RC, Winter DL, Keuhni CE, et al. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. Heart. 2020.

  • Gebauer J, Baust K, Bardi E, Grabow D, Stein A, van der Pal HJ, et al. Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work. Oncology research and treatment. 2020;43(3):61-9.

  • Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, et al. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020;32:106227.

  • Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, et al. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. European journal of cancer. 2020;138:212-24.

  • Mazzei-Abba A, Folly CL, Coste A, Wakeford R, Little MP, Raaschou-Nielsen O, et al. Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives. Journal of radiological protection : official journal of the Society for Radiological Protection. 2020;40(1):R1-R23.

  • Reulen RC, Wong KF, Bright CJ, Winter DL, Alessi D, Allodji RM, et al. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Gut. 2020.

Veröffentlichungen aus 2019

  • Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. European journal of cancer. 2019;117:71-83.

  • Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, et al. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR research protocols. 2019;8(3):e11868.

  • Gebauer J, Calaminus G, Baust K, Grabow D, Kaatsch P, Langer T. Beobachtung von Langzeitnebenwirkungen bei Überlebenden kindlicher Krebserkrankungen. Forum. 2019.

  • Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry - Annual Report 2018 (1980-2017). Mainz: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz; 2019.

  • Kraywinkel K, Spix C. Epidemiologie primärer Hirntumoren bei Kindern und Erwachsenen in Deutschland. Der Onkologe 2019;25:5–9.

  • Mazzei-Abba A, Folly CL, Coste A, Wakeford R, Little MP, Raaschou-Nielsen O, et al. Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives. Journal of radiological protection : official journal of the Society for Radiological Protection. 2019;40(1):R1-r23.

  • Scholtes C, Baust K, Weinhold L, Creutzig U, Gnekow A, Hinz A, et al. Health status, Health-Related Quality of Life and Socio-economic Outcome in Childhood Brain Tumor Survivors: a German Cohort Study. Neuro Oncol. 2019.

Veröffentlichungen aus 2018

  • Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, et al. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. Journal of the National Cancer Institute. 2018;110(6):649-60.

  • Byrne J, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, et al. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. European journal of cancer. 2018;103:238-48.

  • Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, et al. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. European journal of cancer. 2018;103:227-37.

  • Dantonello TM, Vokuhl C, Scheer M, Sparber-Sauer M, Stegmaier S, Seitz G, et al. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis? Virchows Archiv : an international journal of pathology. 2018;472(3):441-9.

  • Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Munzel T, et al. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J. 2018;39(17):1555-62.

  • Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bardi E, et al. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. Journal of the National Cancer Institute. 2018;110(2).

  • Gebauer J, Lehnert H, Schmid SM, Spix C, Stein A, Langer T. [Late effects following childhood cancer treatment : A special challenge for transition medicine]. Der Internist. 2018;59(11):1157-62.

  • Gebauer J, Spix C, Brabant G, Langer T. Endokrine Spätfolgen nach onkologischer Therapie im Kindesalter. Der Onkologe. 2018;24(10):790-6.

  • Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. European journal of epidemiology. 2018;33(3):335-49.

  • Grabow D, Kaatsch P. Europäische PanCare-Studien zu Spätfolgen nach Krebs im Kindes- und Jugendalter. Der Onkologe. 2018;24(10):754-9.

  • Jankovic M, Haupt R, Spinetta JJ, Beck JD, Byrne J, Calaminus G, et al. Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016). J Cancer Surviv. 2018;12(5):647-50.

  • Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry - Annual Report 2017 (1980-2016). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz; 2018.

  • Langer T, Grabow D, Kaatsch P, Creutzig U, Eggert A, Escherich G, et al. [Long-Term Follow-Up in Childhood Cancer Survivors - Position paper 2018 of the working group "long-term follow-up" of the Society of Pediatric Oncology and Hematology (GPOH) on long-term surveillance, long-term follow-up and late effect evaluation in pediatric oncology patients]. Klinische Padiatrie. 2018;230(6):291-8.

  • Mensah J, Kowalski C, Grabow D, Spix C, Kaatsch P. Möglichkeiten zur Versorgungsforschung bei Überlebenden nach Krebs im Kindesalter. Onkologie heute. 2018(8/2018).

  • Panova-Noeva M, Neu MA, Eckerle S, Spix C, Schneider A, Schmidtmann I, et al. Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer. Clinical research in cardiology : official journal of the German Cardiac Society. 2018.

  • Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, et al. Second primary cancer after childhood cancer in Germany 1980-2014 – a registry based analysis Deutsches Ärzteblatt. 2018.

  • Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, et al. Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014. Deutsches Arzteblatt international. 2018;115(23):385-92.

  • Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Pineros M, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study. The lancet oncology. 2018;19(9):1159-69.

  • van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol. BMC cancer. 2018;18(1):930.

  • van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, et al. Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). JMIR research protocols. 2018;7(9):e10824.


Veröffentlichungen aus 2017

  • Berthold F, Spix C, Kaatsch P, Lampert F. Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015. Paediatric drugs. 2017;19(6):577-93.

  • Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, et al. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. Journal of the National Cancer Institute. 2017.

  • Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sanchez MJ, et al. Geographical variability in survival of European children with central nervous system tumours. European journal of cancer. 2017;82:137-48.

  • Grosche B, Kaatsch P, Heinzow B, Wichmann HE. The Krummel (Germany) Childhood Leukaemia Cluster: a review and update. Journal of radiological protection : official journal of the Society for Radiological Protection. 2017;37(4):R43-r58.

  • Kraywinkel K, Spix C. Epidemiologie akuter Leukämien in Deutschland. Der Onkologe. 2017;23(7):499-503.

  • Krille L, Dreger S, Schindel R, Albrecht T, Asmussen M, Barkhausen J, et al. Erratum to: Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study. Radiation and environmental biophysics. 2017;56(3):293-7.

  • Langer T, Grabow D, Steinmann D, Wormann B, Calaminus G. Late Effects and Long-Term Follow-Up after Cancer in Childhood. Oncology research and treatment. 2017;40(12):746-50.

  • Petersen I, Kaatsch P, Spix C, Kollek R. Return and Disclosure of Research Results: Parental Attitudes and Needs Over Time in Pediatric Oncology. The Journal of pediatrics. 2017;191:232-7.

  • Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American journal of medical genetics Part A. 2017;173(4):1017-37.

  • Scholz-Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, et al. Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: A systematic review and meta-analysis. Pediatric blood & cancer. 2017;64(7).

  • Spix C, Grosche B, Bleher M, Kaatsch P, Scholz-Kreisel P, Blettner M. Background gamma radiation and childhood cancer in Germany: an ecological study. Radiation and environmental biophysics. 2017;56(2):127-38.
  • Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. The lancet oncology. 2017;18(6):719-31.

  • Steliarova-Foucher E, Colombet M, Ries LAG, Hesseling P, Moreno F, Shin HY, et al. International Incidence of Childhood Cancer, Volume III (electronic version).  2017 accessed [20.6.2017].

Veröffentlichungen aus 2016

  • Becker C, Blettner M, Kaatsch P, Ressing M, S. Z. Welche Daten zu Krebs und zur Mortalität findet man in Deutschland? . Strahlenschutz Praxis. 2016;2/2016 (22):34-8

  • Decarolis B, Simon T, Krug B, Leuschner I, Vokuhl C, Kaatsch P, et al. Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed. BMC cancer. 2016;16:542.

  • Etzold A, Galetzka D, Weis E, Bartsch O, Haaf T, Spix C, et al. CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue. Epigenetics : official journal of the DNA Methylation Society. 2016;11(2):120-31.

  • Feijen EA, Font-Gonzalez A, van Dalen EC, van der Pal HJ, Reulen RC, Winter DL, et al. Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. PloS one. 2016;11(9):e0162778.

  • Gunst DC, Kaatsch P, Goldbeck L. Seeing the good in the bad: which factors are associated with posttraumatic growth in long-term survivors of adolescent cancer? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2016;24(11):4607-15.

  • Kaatsch P, Strothotte J, Becker C, Bielack S, Dirksen U, Blettner M. Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival. Acta oncologica. 2016;55(9-10):1145-51.

  • Langer T, Kaatsch P, Steinmann D, Calaminus G. Spätfolgen von Tumoren im Kindesalter. Der Onkologe. 2016;22(12):970-7.

  • Metayer C, Petridou E, Arangure JM, Roman E, Schuz J, Magnani C, et al. Parental Tobacco Smoking and Acute Myeloid Leukemia: The Childhood Leukemia International Consortium. American journal of epidemiology. 2016;184(4):261-73.

  • Spix C, Berthold F, Hero B, Michaelis J, Schilling FH. Correction factors for self-selection when evaluating screening programmes. Journal of medical screening. 2016;23(1):44-9.

  • Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, et al. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5. The lancet oncology. 2016;17(7):896-906.

  • Weber ML, Schneider DT, Offenmuller S, Kaatsch P, Einsiedel HG, Benesch M, et al. Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes. Pediatric blood & cancer. 2016;63(4):611-7.

  • Zuzak TJ, Kameda G, Schutze T, Kaatsch P, Seifert G, Bailey R, et al. Contributing factors and outcomes of treatment refusal in pediatric oncology in Germany. Pediatric blood & cancer. 2016;63(10):1800-5.

-------------------------------------------------------------------------------------------------

Archivierte Publikationen von 2001 bis 2015 finden Sie unter Archiv oder hier...